SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : IATV-ACTV Digital Convergence Software-HyperTV -- Ignore unavailable to you. Want to Upgrade?


To: StaggerLee who wrote (3777)5/18/1999 9:04:00 AM
From: Mike Fredericks  Read Replies (3) | Respond to of 13157
 
Bill Samuels' 2% market cap bonus is a completely separate issue. It has nothing to do with what is being voted on this week. Item #2 on the proxy authorizes management to grant themselves 1.5 million options

All I know is that I read that darn proxy 3 or 4 times and it's sort of confusing, but it definitely talks about the 2% market cap bonus in the same area as it talks about the rest of the compensation plan. My read is that #2 includes the 2% bonus, the executive options plan, and the options plan for everyone else who works there. I could be wrong, as the proxy statement, like every other document filed with the SEC, is written to minimize the number of people who understand it.

-Mike



To: StaggerLee who wrote (3777)5/18/1999 11:42:00 AM
From: art slott  Respond to of 13157
 
>>As I said earlier, I don't think management cost themselves anything in opting out of the SARS plan. They merely limited their compensation (as legally defined), NOT the vested amount of their SARS. They also agreed to be paid in stock instead of cash for those vested amounts.<<

Could you explain what you mean by "Not the vested amount of their SARS". Sounds like hair splitting to me. What difference does it make? They saved the company $3.2 million. They will be paid in stock and they had the foresight and benevolence to correct the problem.

Btw the SARS were issued in 92 and capped at 900k. and option #2 as you are well aware has nothing to do with SARS.